Journal of AIDS & Clinical Research

Jorge Sandoval-Ramírez

Publications

• Research Article
  Dyslipidemia and Fasting Glucose Impairment among HIV-Infected Patients 48-Weeks after the First Antiretroviral Regimen
  Author(s): José Antonio Mata-Marín, Bulmaro Manjarrez-Téllez, Jesús Gaytán-Martínez, Marcelino Chávez-García, Marco Isaac Banda-Lara, Corina Ortega-Ortiz, Nohemí Nuñez-Rodríguez, Juan Carlos Domínguez-Hermosillo Juan, Gloria Huerta-García, Javier Enrique Cruz-Herrera, Rocío Zapata-López and Jorge Sandoval-RamírezJosé Antonio Mata-Marín, Bulmaro Manjarrez-Téllez, Jesús Gaytán-Martínez, Marcelino Chávez-García, Marco Isaac Banda-Lara, Corina Ortega-Ortiz, Nohemí Nuñez-Rodríguez, Juan Carlos Domínguez-Hermosillo Juan, Gloria Huerta-García, Javier Enrique Cruz-Herrera, Rocío Zapata-López and Jorge Sandoval-Ramírez
  
  Background: People infected with human immunodeficiency virus (HIV) develop lipid and glucose metabolic alterations, which predisposes them to cardiovascular disease. The aim of this study was to evaluate the cumulative incidence of dyslipidemia and fasting glucose impairment after 48 weeks of initiating the first antiretroviral (ART) regimen and the association with the type of ART regimen. Method: Retrospective cohort of HIV-1 infected patients attending in the AIDS clinic of five centers of the country, between February 2009 and March 2013. Lipids (total cholesterol and triglycerides) and fasting glucose, were collected prior and 48 weeks after starting ART. We assessed risk factors for dyslipidemia and fasting glucose. To adjust for the effects of potential confounders of metabolic alterations we used logistic regression model. Results: During .. Read More»
  DOI: 10.4172/2155-6113.1000533

  Abstract PDF